share_log

京东健康618战报:解热镇痛用药与五官用药成交额同比增长均超9倍

JD.com Health 618 Battle report: the turnover of antipyretic analgesics and facial features drugs has increased by more than 9 times compared with the same period last year.

金融界 ·  Jun 18, 2021 16:50

Original title: JD.com Health 618 Battle report: the turnover of antipyretic analgesics and facial features drugs has increased more than 9 times year-on-year. Source: financial circles Network

During the period of JD.com Health 618, household medicine is still the rigid demand of consumers for "hoarding". In the first 10 minutes of June 18, the turnover of antipyretic analgesics and facial features drugs at JD.com Pharmacy increased by more than 9 times compared with the same period last year, pediatrics by more than 8 times, and tonifying and tranquilizing drugs by 5 times compared with the same period last year.

1bbb-krpikqf8462252.jpg

In addition, in the first 10 minutes, the sales of Alovinic acid tablets exceeded 150000 tablets, and the order volume of hair loss brand Mandilaudil tincture exceeded 6000 bottles; in the first 30 minutes, the turnover of JD.com health medicine increased by 157% compared with the same period last year. The first order took place in Zhongshan, Guangdong Province, and the order was completed within 15 minutes. The goods to be issued were Golden throat Bao, cool throat tablets, South China Vitamin C and so on.

f638-krpikqf8462158.jpg

Today, JD.com Pharmacy has achieved full coverage of common diseases, chronic diseases, daily health care, health care and nourishment, as well as new special drugs and rare disease medicines; its self-supporting cold chain capability announced in May has also covered more than 100 cities across the country as of June 1. JD.com Health continues to be hot. JD.com Health will provide more health products and health services, as well as one-stop health management solutions, so that more users can experience customized health management services in their daily life and start a healthy life.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment